Dalian BIO-CHEM Company Limited
603360.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| % Growth | 23.1% | -15.2% | 24.9% | – |
| Cost of Goods Sold | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Gross Profit | CN¥1 | CN¥1 | CN¥1 | CN¥0 |
| % Margin | 43.8% | 51.1% | 51% | 44.7% |
| R&D Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| G&A Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| SG&A Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Sales & Mktg Exp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Other Operating Expenses | -CN¥0 | -CN¥0 | -CN¥0 | CN¥0 |
| Operating Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Operating Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 31.6% | 36.2% | 36.7% | 30.1% |
| Other Income/Exp. Net | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Pre-Tax Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Tax Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 26.3% | 30.8% | 32% | 24.9% |
| EPS | 0.68 | 0.66 | 1.2 | 0.71 |
| % Growth | 3% | -45% | 69% | – |
| EPS Diluted | 0.68 | 0.93 | 1.2 | 0.71 |
| Weighted Avg Shares Out | 1 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Interest Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Depreciation & Amortization | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| EBITDA | CN¥0 | CN¥0 | CN¥1 | CN¥0 |
| % Margin | 35.3% | 41.3% | 41.1% | 35.1% |